510(k) Report

510(k) · Cleared

Cleared

Penumbra System 110 Aspiration Tubing

K151623510(k) SpecialCleared Aug 6, 201551-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Penumbra, Inc. · NRY Catheter, Thrombus Retriever

Cleared on Aug 6, 2015 as substantially equivalent to K133317 (Penumbra, Inc., 2014) and 1 other predicate after a 51-day review. Its family tree reaches back 7 generations to 2001. 2 later devices descend from it.

Decided
Aug 6, 2015
Review
51 days
Class
Class II
Product code
NRY
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K003410 (2001). 10 ancestors in all, the oldest K003086 (2001). 2 later devices descend from it, 1 citing it directly.

  1. Root · 7 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 6 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
  3. 5 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
  4. 4 generations backK072718 Penumbra SystemPenumbra, Inc. · 2007 · Recalled
  5. 3 generations backK100769 Penumbra System Separator Flex (026,032,041,054), Models PSF026…Penumbra, Inc. · 2010
  6. 2 generations backK113163 Penumbra System MaxPenumbra, Inc. · 2011
  7. 1 generation backK142458 Penumbra System ACEPenumbra, Inc. · 2015
  8. This deviceK151623 Penumbra System 110 Aspiration TubingPenumbra, Inc. · 2015
  9. Descendant · cites it directly · 1 of its ownK182522 Penumbra System (Modified 110 Aspiration Tubing)Penumbra, Inc. · 2018
  10. Descendant · 2 generations on · 0 of its ownK250690 Penumbra System (Thunderbolt Aspiration Tubing)Penumbra, Inc. · 2026 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K182522Penumbra System (Modified 110 Aspiration Tubing)Penumbra, Inc. · 2018 · cites it directly1descendant
  • K250690Penumbra System (Thunderbolt Aspiration Tubing)Penumbra, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K003410Concentric Retriever, Model 90030Concentric Medical, Inc.20011
−6K030476Modified Concentric Retriever, Model 90037Concentric Medical, Inc.20032
−5K033736Merci Retriever, Models 90065, 90066Concentric Medical, Inc.2004—
−4K072718Penumbra SystemPenumbra, Inc.20071
−3K100769Penumbra System Separator Flex (026,032,041,054), Models PSF026, PSF032…Penumbra, Inc.2010—
−2K113163Penumbra System MaxPenumbra, Inc.2011—
−1K142458Penumbra System ACEPenumbra, Inc.2015—
0 (this device)K151623Penumbra System 110 Aspiration TubingPenumbra, Inc.2015—
+1K182522Penumbra System (Modified 110 Aspiration Tubing)Penumbra, Inc.2018—
+2K250690Penumbra System (Thunderbolt Aspiration Tubing)Penumbra, Inc.20261

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200910
201410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202610
FIG. 1 — Lineage of K151623, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NRY device

  1. #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133317Penumbra System / Penumbra System Max
Summary page 5
…ate Devices 510(k) Number / Clearance Name of Predicate Device Name of Manufacturer Date K133317 [13MAY2014] Penumbra System® and Penumbra, Inc. Penumbra System MAX®…
Penumbra, Inc.2014—
*K142458Penumbra System ACE
Summary page 5
…enumbra, Inc. Penumbra System MAX® One Penumbra Place K142458 [22May2015] Penumbra System® ACE 64 and Alameda, CA 94502 USA ACE 68 Reperfusion…
Penumbra, Inc.2015—

Also cleared against K133317: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K182522Penumbra System (Modified 110 Aspiration Tubing)Penumbra, Inc.20181

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 2 companies; a new generation was cleared every 1.8 years on median.
  • 3 of the 10 ancestors have a recall of any class.
  • Of its descendants, K182522 (Penumbra, Inc., 2018) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K133317.

How does its category compare?

All NRY devices

NRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · NRY

15in 2025

2007: 52008: 22009: 22010: 12011: 22012: 42014: 42015: 62016: 52017: 32018: 112019: 72020: 62021: 92022: 32023: 82024: 82025: 152026 (partial year): 14
2007high 15 (2025) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NRY

129in 2025

2007: 94 days median2012: 90 days median2014: 140 days median2015: 128 days median2016: 75 days median2017: 185 days median2018: 156 days median2019: 89 days median2020: 125 days median2021: 80 days median2022: 129 days median2023: 112 days median2024: 165 days median2025: 129 days median2026 (partial year): 147 days median
2007high 185 (2017) · low 75 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NRY

4in 2020

2010: 12013: 12017: 42020: 4, 4 Class I2026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · NRY

565in 2025

2007: 132008: 182009: 572010: 2892011: 2632012: 3662013: 4052014: 4282015: 5982016: 4972017: 4322018: 4152019: 6502020: 7032021: 6882022: 5492023: 7112024: 6412025: 565
2007high 711 (2023) · low 13 (2007)2025

MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007594013
20082—018
20092—057
20101—1289
20112—0263
20124900366
20130—1405
201441400428
201561280598
20165750497
201731854432
2018111560415
20197890650
202061254 (4)703
20219800688
202231290549
202381120711
202481650641
2025151290565
2026141472—

What is it indicated for?

The Penumbra System / Penumbra System MAX are intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. The Penumbra System is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large…

Read the full statement (118 words)

The Penumbra System / Penumbra System MAX are intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset.

The Penumbra System is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. The Reperfusion Catheters ACE 64 and ACE 68 are intended for use in revascularization within the Internal Carotid Artery (ICA) within 8 hours of symptom onset.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151623: Penumbra System 110 Aspiration Tubing.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151623

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026